Cenerimod matching placebo, Cenerimod 4 mg
ID-064A301
Phase 3 small_molecule active
Quick answer
Cenerimod matching placebo, Cenerimod 4 mg for Moderate to severe systemic lupus erythematosus is a Phase 3 program (small_molecule) at Viatris Pharmaceuticals Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Viatris Pharmaceuticals Co.,
- Indication
- Moderate to severe systemic lupus erythematosus
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active